Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4893

1.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.

2.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

3.

Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2011;11(1):1-93. Epub 2011 Feb 1.

4.

Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.

5.

HeartMate left ventricular assist device as bridge to heart transplantation.

Koul B, Solem JO, Steen S, Casimir-Ahn H, Granfeldt H, Lönn UJ.

Ann Thorac Surg. 1998 Jun;65(6):1625-30.

PMID:
9647070
6.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

7.

Endovascular laser therapy for varicose veins: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(6):1-92. Epub 2010 Apr 1.

8.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
9.

Evaluation of the ventricular assist device programme in the UK.

Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C.

Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. Review.

10.

Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.

Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, Moscucci M, Deeb GM, Bolling S, Monaghan H, Aaronson KD.

Circulation. 1999 Nov 9;100(19 Suppl):II206-10.

11.
12.

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.

Circulation. 1994 Nov;90(5 Pt 2):II83-6.

PMID:
7955290
13.

Coil embolization for intracranial aneurysms: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(1):1-114. Epub 2006 Jan 1.

14.

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.

Pagani FD, Aaronson KD, Swaniker F, Bartlett RH.

Ann Thorac Surg. 2001 Mar;71(3 Suppl):S77-81; discussion S82-5.

PMID:
11265871
15.

Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.

Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A.

Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530. Review.

16.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.

17.

The Papworth experience with the Levitronix CentriMag ventricular assist device.

Shuhaiber JH, Jenkins D, Berman M, Parameshwar J, Dhital K, Tsui S, Large SR.

J Heart Lung Transplant. 2008 Feb;27(2):158-64. doi: 10.1016/j.healun.2007.10.015.

PMID:
18267221
18.

Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience.

Vitali E, Lanfranconi M, Bruschi G, Russo C, Colombo T, Ribera E.

J Card Surg. 2003 Mar-Apr;18(2):107-13.

PMID:
12757336
19.

Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD.

J Am Coll Cardiol. 2011 May 10;57(19):1890-8. doi: 10.1016/j.jacc.2010.10.062. Erratum in: J Am Coll Cardiol. 2011 Nov 8;58(20):2142.

20.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.

Circulation. 2007 Jul 31;116(5):497-505. Epub 2007 Jul 16.

Supplemental Content

Support Center